Newly Approved First-in-Class Treatment for Type 2 Diabetes Is Now Available

BYETTA is the first in a new class of diabetes treatment called incretin mimetics. By mimicking the mechanisms of a naturally occurring human hormone, BYETTA is a diabetes self regulating drug that stays in the blood system, working actively only when blood sugar levels are too high. In clinical trials, BYETTA was shown to help patients regulate blood sugar levels. Most patients in the long-term BYETTA clinical studies also experienced reductions in weight."
Newly Approved First-in-Class Treatment for Type 2 Diabetes Is Now Available: "

No comments:

Blog Archive